InvestorsHub Logo

plexrec

02/08/22 3:39 PM

#350054 RE: vg_future #350047

vg--" and the post seemed to be genuine."--good find--thanks !!!

McMagyar

02/08/22 3:43 PM

#350057 RE: vg_future #350047

Thx VG

RedShoulder

02/08/22 4:36 PM

#350065 RE: vg_future #350047

Veliger

I fully expect we see a lot more behind the curtain tomorrow. More transparency with what is going on with PDD (per IR this morning), and where the numerous, other trial starts are (i.e. Fragile X, ultra rare diseases). At a minimum there will be definitive answers for RETT filing strategy and when. Any dialogue or Q&A around partnership would also be welcome. I’d love to see this serve as catalyst for some upgrades, following avatar data and strategy.



Thanks vg_future for relaying the post, we will see soon if that has any substance.

I post over on that ST board, and every now and again get a gem, like from the Australian 'Mighty Kurtz' (sp) with his personal account of the AD trial patients not only experiencing the stop in the disease progression, but returning to normal. He personally knows the man running the trial there, went to school with him. He was very excited about it, and says the drug is the real deal.

FitzyP33

02/09/22 1:21 PM

#350270 RE: vg_future #350047

Well, so far none of this is true.

Maybe the call will be different this time. Normally Missling just reads the press release which had none of this info.

If he doesn't verbally walk through all the details of Rett, the FDA, etc. Missling is making a big mistake.

The analysts have got to press him as well.

If it were me I wouldn't take questions from the Canter guy who cut the target by $11 or 40%.